Literature DB >> 7515683

Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein.

S Hober1, A Hansson, M Uhlén, B Nilsson.   

Abstract

Insulin-like growth factor I (IGF-I) is thermodynamically unable to quantitatively form its native disulfides under reversible redox conditions in vitro [Hober et al. (1992) Biochemistry 31, 1749-1756]. These results prompted the question of how IGF-I may overcome this energetic problem in its folding in vivo. Here, we report that an IGF-I precursor, IGF-I-Ea, shows disulfide-exchange folding properties similar to those of mature IGF-I and, thus, is concluded not to overcome the identified folding problem of mature IGF-I. However, correct disulfide bonds are formed very efficiently when insulin-like growth factor binding protein 1 is added in equimolar amounts to IGF-I to the refolding mixture. On the basis of these results, we propose that one important function of at least one of the six homologous insulin-like growth factor binding proteins is to assist in the formation and maintenance of the native disulfides of IGF-I. To our knowledge, this is the first example where the folding of a mammalian protein or peptide in circulation has been demonstrated to be thermodynamically controlled by its binding protein. Speculatively, this could provide a mechanism to regulate the half-life of IGF-I in vivo by altering the interaction with insulin-like growth factor binding proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515683     DOI: 10.1021/bi00188a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Deciphering the hidden informational content of protein sequences: foldability of proinsulin hinges on a flexible arm that is dispensable in the mature hormone.

Authors:  Ming Liu; Qing-xin Hua; Shi-Quan Hu; Wenhua Jia; Yanwu Yang; Sunil Evan Saith; Jonathan Whittaker; Peter Arvan; Michael A Weiss
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

2.  Overexpression of Escherichia coli oxidoreductases increases recombinant insulin-like growth factor-I accumulation.

Authors:  J C Joly; W S Leung; J R Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

3.  Oxidation of human insulin-like growth factor I in formulation studies: kinetics of methionine oxidation in aqueous solution and in solid state.

Authors:  J Fransson; E Florin-Robertsson; K Axelsson; C Nyhlén
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

4.  Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties.

Authors:  S J Milner; G L Francis; J C Wallace; B A Magee; F J Ballard
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

5.  A peptide model of insulin folding intermediate with one disulfide.

Authors:  Han Yan; Zhan-Yun Guo; Xiao-Wen Gong; Dan Xi; You-Min Feng
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

6.  Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family.

Authors:  Youhei Sohma; Qing-xin Hua; Ming Liu; Nelson B Phillips; Shi-Quan Hu; Jonathan Whittaker; Linda J Whittaker; Aubree Ng; Charles T Roberts; Peter Arvan; Stephen B H Kent; Michael A Weiss
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

Review 7.  Islet autoantigens: structure, function, localization, and regulation.

Authors:  Peter Arvan; Massimo Pietropaolo; David Ostrov; Christopher J Rhodes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

8.  Peptide models of four possible insulin folding intermediates with two disulfides.

Authors:  Xiao-Yuan Jia; Zhan-Yun Guo; Yao Wang; Ye Xu; Shun-Shan Duan; You-Min Feng
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

9.  Crystal structure of a "nonfoldable" insulin: impaired folding efficiency despite native activity.

Authors:  Ming Liu; Zhu-Li Wan; Ying-Chi Chu; Hassan Aladdin; Birgit Klaproth; Meredith Choquette; Qing-Xin Hua; Robert B Mackin; J Sunil Rao; Pierre De Meyts; Panayotis G Katsoyannis; Peter Arvan; Michael A Weiss
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

Review 10.  Diabetes mellitus due to the toxic misfolding of proinsulin variants.

Authors:  Michael A Weiss
Journal:  FEBS Lett       Date:  2013-05-10       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.